255 related articles for article (PubMed ID: 32460301)
1. Does the Presence of Significant Mitral Regurgitation prior to Transcatheter Aortic Valve Implantation for Aortic Stenosis Impact Mortality? - Meta-Analysis and Systematic Review.
Sethi A; Kodumuri V; Prasad V; Chaudhary A; Coromilas J; Kassotis J
Cardiology; 2020; 145(7):428-438. PubMed ID: 32460301
[TBL] [Abstract][Full Text] [Related]
2. Tricuspid but not Mitral Regurgitation Determines Mortality After TAVI in Patients With Nonsevere Mitral Regurgitation.
Amat-Santos IJ; Castrodeza J; Nombela-Franco L; Muñoz-García AJ; Gutiérrez-Ibanes E; de la Torre Hernández JM; Córdoba-Soriano JG; Jiménez-Quevedo P; Hernández-García JM; González-Mansilla A; Ruano J; Tobar J; Del Trigo M; Vera S; Puri R; Hernández-Luis C; Carrasco-Moraleja M; Gómez I; Rodés-Cabau J; San Román JA
Rev Esp Cardiol (Engl Ed); 2018 May; 71(5):357-364. PubMed ID: 29079280
[TBL] [Abstract][Full Text] [Related]
3. Impact of mitral regurgitation on clinical outcomes of patients with low-ejection fraction, low-gradient severe aortic stenosis undergoing transcatheter aortic valve implantation.
O'Sullivan CJ; Stortecky S; Bütikofer A; Heg D; Zanchin T; Huber C; Pilgrim T; Praz F; Buellesfeld L; Khattab AA; Blöchlinger S; Carrel T; Meier B; Zbinden S; Wenaweser P; Windecker S
Circ Cardiovasc Interv; 2015 Feb; 8(2):e001895. PubMed ID: 25657315
[TBL] [Abstract][Full Text] [Related]
4. Mitral Regurgitation in Low-Flow, Low-Gradient Aortic Stenosis Patients Undergoing TAVR: Insights From the TOPAS-TAVI Registry.
Freitas-Ferraz AB; Lerakis S; Barbosa Ribeiro H; Gilard M; Cavalcante JL; Makkar R; Herrmann HC; Windecker S; Enriquez-Sarano M; Cheema AN; Nombela-Franco L; Amat-Santos I; Muñoz-García AJ; Garcia Del Blanco B; Zajarias A; Lisko JC; Hayek S; Babaliaros V; Le Ven F; Gleason TG; Chakravarty T; Szeto WY; Clavel MA; de Agustin A; Serra V; Schindler JT; Dahou A; Annabi MS; Pelletier-Beaumont E; Pibarot P; Rodés-Cabau J
JACC Cardiovasc Interv; 2020 Mar; 13(5):567-579. PubMed ID: 32061600
[TBL] [Abstract][Full Text] [Related]
5. Impact of preprocedural mitral regurgitation upon mortality after transcatheter aortic valve implantation (TAVI) for severe aortic stenosis.
Khawaja MZ; Williams R; Hung J; Arri S; Asrress KN; Bolter K; Wilson K; Young CP; Bapat V; Hancock J; Thomas M; Redwood S
Heart; 2014 Nov; 100(22):1799-803. PubMed ID: 25155800
[TBL] [Abstract][Full Text] [Related]
6. Meta-analysis of the impact of mitral regurgitation on outcomes after transcatheter aortic valve implantation.
Chakravarty T; Van Belle E; Jilaihawi H; Noheria A; Testa L; Bedogni F; Rück A; Barbanti M; Toggweiler S; Thomas M; Khawaja MZ; Hutter A; Abramowitz Y; Siegel RJ; Cheng W; Webb J; Leon MB; Makkar RR
Am J Cardiol; 2015 Apr; 115(7):942-9. PubMed ID: 25779617
[TBL] [Abstract][Full Text] [Related]
7. Meta-analysis of mortality outcomes and mitral regurgitation evolution in 4,839 patients having transcatheter aortic valve implantation for severe aortic stenosis.
Sannino A; Losi MA; Schiattarella GG; Gargiulo G; Perrino C; Stabile E; Toscano E; Giugliano G; Brevetti L; Franzone A; Cirillo P; Imbriaco M; Trimarco B; Esposito G
Am J Cardiol; 2014 Sep; 114(6):875-82. PubMed ID: 25092192
[TBL] [Abstract][Full Text] [Related]
8. Mitral regurgitation prior to transcatheter aortic valve implantation influences survival but not symptoms.
Boerlage-van Dijk K; Wiegerinck EM; Takama T; Koch KT; Vis MM; de Mol BA; Piek JJ; Bouma BJ; Baan J
Int J Cardiol; 2016 Feb; 204():95-100. PubMed ID: 26655549
[TBL] [Abstract][Full Text] [Related]
9. The predictive value of baseline pulmonary hypertension in early and long term cardiac and all-cause mortality after transcatheter aortic valve implantation for patients with severe aortic valve stenosis: A systematic review and meta-analysis.
Kokkinidis DG; Papanastasiou CA; Jonnalagadda AK; Oikonomou EK; Theochari CA; Palaiodimos L; Karvounis HI; Armstrong EJ; Faillace RT; Giannakoulas G
Cardiovasc Revasc Med; 2018; 19(7 Pt B):859-867. PubMed ID: 29724516
[TBL] [Abstract][Full Text] [Related]
10. Transcatheter aortic valve implantation reduces grade of concomitant mitral and tricuspid valve regurgitation and pulmonary hypertension.
Wilbring M; Tugtekin SM; Ritzmann M; Arzt S; Schmidt T; Matschke K; Kappert U; Alexiou K
Eur J Cardiothorac Surg; 2014 Nov; 46(5):818-24. PubMed ID: 24574441
[TBL] [Abstract][Full Text] [Related]
11. Impact of Transcatheter Aortic Valve Implantation Among Patients With Co-existing Mild to Moderate Mitral Regurgitation.
Twing AH; Gokhale S; Slostad B; Meyer J; Simon E; Dickens H; Kaluzna SD; Groo V; Kansal M; Shroff A; Groves EM
Am J Cardiol; 2022 Aug; 177():84-89. PubMed ID: 35732551
[TBL] [Abstract][Full Text] [Related]
12. Comparison of Early and Long-Term Outcomes After Transcatheter Aortic Valve Implantation in Patients with New York Heart Association Functional Class IV to those in Class III and Less.
Adamo M; Fiorina C; Petronio AS; Giannini C; Tamburino C; Barbanti M; Bedogni F; Testa L; Colombo A; Latib A; Bruschi G; Reimers B; Poli A; Nazzaro MS; Curello S; Ettori F
Am J Cardiol; 2018 Nov; 122(10):1718-1726. PubMed ID: 30227961
[TBL] [Abstract][Full Text] [Related]
13. Prognostic impact and change of concomitant mitral regurgitation after surgical or transcatheter aortic valve replacement for aortic stenosis.
Fojt R; Moťovská Z; Budera P; Malý M; Straka Z
J Cardiol; 2016 Jun; 67(6):526-30. PubMed ID: 26972342
[TBL] [Abstract][Full Text] [Related]
14. Relationship between Mitral Regurgitation and Transcatheter Aortic Valve Implantation: a Multi-Institutional Follow-up Study.
Cunha LCBPD; Guerios EE; Cunha CLPD; Carvalho LA; Lemos Neto P; Sarmento-Leite R; Abizaid AA; Mangione JA; Oliveira AD; Siciliano A; Esteves V; Brito FS
Arq Bras Cardiol; 2021 Jun; 116(6):1059-1069. PubMed ID: 34133587
[TBL] [Abstract][Full Text] [Related]
15. Five-year follow-up after transcatheter aortic valve implantation for symptomatic aortic stenosis.
Zahn R; Werner N; Gerckens U; Linke A; Sievert H; Kahlert P; Hambrecht R; Sack S; Abdel-Wahab M; Hoffmann E; Zeymer U; Schneider S;
Heart; 2017 Dec; 103(24):1970-1976. PubMed ID: 28684438
[TBL] [Abstract][Full Text] [Related]
16. Fate and long-term prognostic implications of mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
Abdelghani M; Abdel-Wahab M; Hemetsberger R; Landt M; Merten C; Toelg R; Richardt G
Int J Cardiol; 2019 Aug; 288():39-43. PubMed ID: 30948219
[TBL] [Abstract][Full Text] [Related]
17. The beneficial effects of TAVI in mitral insufficiency.
Costantino MF; Dores E; Innelli P; Matera A; Santillo V; Violini R; Fiorilli R; Cappabianca G; Marraudino N; Picano E; Tarsia G
Cardiovasc Ultrasound; 2015 Dec; 13():49. PubMed ID: 26714887
[TBL] [Abstract][Full Text] [Related]
18. Transcatheter aortic valve implantation in patients with concomitant mitral and tricuspid regurgitation.
Hutter A; Bleiziffer S; Richter V; Opitz A; Hettich I; Mazzitelli D; Ruge H; Lange R
Ann Thorac Surg; 2013 Jan; 95(1):77-84. PubMed ID: 23063197
[TBL] [Abstract][Full Text] [Related]
19. [Outcome comparison of different therapy procedures in surgical high-risk elderly patients with severe aortic stenosis].
Ye YQ; Wang YT; Li Z; Wang MY; Xu HY; Zhang WJ; Liu QR; Niu GN; Wu YJ
Zhonghua Xin Xue Guan Bing Za Zhi; 2017 Jan; 45(1):13-18. PubMed ID: 28100340
[No Abstract] [Full Text] [Related]
20. Association between calcifications of mitro-aortic continuity and mitral regurgitation in patients undergoing transcatheter aortic valve replacement.
Ryś M; Hryniewiecki T; Witkowski A; Michałowska I; Zatorska K; Stokłosa P; Nieznańska M; Szymański P
Kardiol Pol; 2021; 79(6):669-675. PubMed ID: 33926170
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
